'%3e%3cg%20id='mkuqs0y719954117'%20opacity='1'%20style='mix-blend-mode:normal'%3e%3cg%3e%3cg%3e%3cg%20id='mkuqs0y821269793_translate'%3e%3cg%20transform='matrix(1,0,0,1,1.1796999999999969,1.1796999999999969)'%3e%3cg%20id='mkuqs0y821269793'%20opacity='1'%20style='mix-blend-mode:normal'%3e%3cg%3e%3cg%3e%3cpath%20id='mkuqs0y821269793_fill_path'%20d='M48.82031,0c13.86456,0.00003%2026.37902,5.77981%2035.26611,15.06104l-14.05957,14.93896c0,0%20-23.81334,-0.16351%20-27.38623,0c-3.57289,0.16351%20-6.41943,3.32226%20-6.41943,6.93555c0.00025,3.71799%203.01438,6.73193%206.73242,6.73193h11.1792c9.24095,0.00003%2016.73231,7.4915%2016.73242,16.73242c-0.00013,9.24091%20-7.49148,16.7324%20-16.73242,16.73242h-20.8335l-4.76758,4.79004c5.90399,3.62636%2012.85185,5.71826%2020.28857,5.71826c21.43975,-0.00005%2038.82026,-17.38057%2038.82031,-38.82031c0,-5.66398%20-1.21347,-11.04437%20-3.39404,-15.896l7.29443,-7.75049c3.88606,7.0057%206.09961,15.06749%206.09961,23.64648c-0.00005,26.96259%20-21.85772,48.82026%20-48.82031,48.82031c-26.96263,0%20-48.82026,-21.85769%20-48.82031,-48.82031c0,-26.96266%2021.85765,-48.82031%2048.82031,-48.82031zM48.82031,10c-21.43982,0%20-38.82031,17.3805%20-38.82031,38.82031c0.00002,10.38271%204.07608,19.81347%2010.71533,26.7793l8.42773,-8.46729h24.98975c3.71809,-0.00003%206.73229,-3.01435%206.73242,-6.73242c-0.00011,-3.71808%20-3.01432,-6.7324%20-6.73242,-6.73242h-11.1792c-9.24089,0%20-16.73217,-7.49111%20-16.73242,-16.73193c0,-9.24104%207.49138,-16.73242%2016.73242,-16.73242h23.97949l3.65186,-3.53223c-6.20753,-4.21062%20-13.69873,-6.67088%20-21.76465,-6.6709z'%20fill-rule='evenodd'%20fill='rgb(109,%20211,%20165)'%20fill-opacity='1'%20style='mix-blend-mode:normal'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/g%3e%3canimateTransform%20href='%23mkuqs0y821269793'%20attributeName='transform'%20type='translate'%20values='48.8203%2048.8203;48.8203%2048.8203;48.8203%2048.8203;48.8203%2048.8203'%20dur='1.3s'%20repeatCount='indefinite'%20calcMode='spline'%20keyTimes='0;0.51;0.99;1'%20keySplines='0.5%200.35%200.15%201;0.5%200.35%200.15%201;0.5%200.35%200.15%201'%20additive='sum'%20fill='freeze'%3e%3c/animateTransform%3e%3canimateTransform%20href='%23mkuqs0y821269793'%20attributeName='transform'%20type='scale'%20values='1%201;0.6%200.6;1%201;1%201'%20dur='1.3s'%20repeatCount='indefinite'%20calcMode='spline'%20keyTimes='0;0.51;0.99;1'%20keySplines='0.5%200.35%200.15%201;0.5%200.35%200.15%201;0.5%200.35%200.15%201'%20additive='sum'%20fill='freeze'%3e%3c/animateTransform%3e%3canimateTransform%20href='%23mkuqs0y821269793'%20attributeName='transform'%20type='translate'%20values='-48.8203%20-48.8203;-48.8203%20-48.8203;-48.8203%20-48.8203;-48.8203%20-48.8203'%20dur='1.3s'%20repeatCount='indefinite'%20calcMode='spline'%20keyTimes='0;0.51;0.99;1'%20keySplines='0.5%200.35%200.15%201;0.5%200.35%200.15%201;0.5%200.35%200.15%201'%20additive='sum'%20fill='freeze'%3e%3c/animateTransform%3e%3canimate%20href='%23mkuqs0y821269793'%20attributeName='opacity'%20values='1;0;1;1'%20dur='1.3s'%20repeatCount='indefinite'%20calcMode='spline'%20keyTimes='0;0.51;0.99;1'%20keySplines='0.5%200.35%200.15%201;0.5%200.35%200.15%201;0.5%200.35%200.15%201'%20additive='replace'%20fill='freeze'%3e%3c/animate%3e%3c/svg%3e)
Giới thiệu công ty
- Mã cổ phiếu
- AZN
- Mã ISIN
- GB0009895292
- Tiền tệ
- US Dollar (USD)
- Ngày IPO
- 1993-05-17
AstraZeneca PLC (AZN)
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company offers Imjudo, Datroway, Iressa, Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Crestor, Andexxa, Onglyza, Symlin, XIGDUO XR, Atacand, Atacand HCT, Atacand Plus,...
NYSEHealthcareDrug Manufacturers - GeneralUSA
Thông tin liên hệ
- Địa chỉ công ty
- 1 Francis Crick Avenue, Cambridge, United Kingdom, CB2 0AA
- Số điện thoại liên hệ
- 44 20 3749 5000
- Website công ty
- https://www.astrazeneca.com
- Kết thúc năm tài chính
- December
Điểm nhấn tài chính
- Giá trị thị trường
- $999,999.99
- Lợi nhuận gộp (TTM)
- $999,999.99
- Tỷ suất cổ tức
- 2.03%
- Lợi nhuận trên tài sản (TTM)
- 8.21%
- EBITDA
- $999,999.99
- Doanh thu (TTM)
- $999,999.99